Your browser doesn't support javascript.
loading
Whole-Exome Sequencing Identifies Pathogenic Germline Variants in Patients with Lynch-Like Syndrome.
Dos Santos, Wellington; de Andrade, Edilene Santos; Garcia, Felipe Antonio de Oliveira; Campacci, Natália; Sábato, Cristina da Silva; Melendez, Matias Eliseo; Reis, Rui Manuel; Galvão, Henrique de Campos Reis; Palmero, Edenir Inez.
Afiliação
  • Dos Santos W; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos 14784-400, São Paulo, Brazil.
  • de Andrade ES; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos 14784-400, São Paulo, Brazil.
  • Garcia FAO; Laboratory of Molecular Diagnosis, Barretos Cancer Hospital, Barretos 14784-400, São Paulo, Brazil.
  • Campacci N; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos 14784-400, São Paulo, Brazil.
  • Sábato CDS; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos 14784-400, São Paulo, Brazil.
  • Melendez ME; Laboratory of Molecular Diagnosis, Barretos Cancer Hospital, Barretos 14784-400, São Paulo, Brazil.
  • Reis RM; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos 14784-400, São Paulo, Brazil.
  • Galvão HCR; Department of Molecular Carcinogenesis, National Cancer Institute, Rio de Janeiro 20231-050, Rio de Janeiro, Brazil.
  • Palmero EI; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos 14784-400, São Paulo, Brazil.
Cancers (Basel) ; 14(17)2022 Aug 31.
Article em En | MEDLINE | ID: mdl-36077770
Lynch syndrome (LS) is the most common hereditary colorectal cancer (CRC) syndrome, characterized by germline pathogenic variants in mismatch repair (MMR)-related genes that lead to microsatellite instability. Patients who meet the clinical criteria for LS and MMR deficiency and without any identified germline pathogenic variants are frequently considered to have Lynch-like syndrome (LLS). These patients have a higher risk of CRC and extracolonic tumors, and little is known about their underlying genetic causes. We investigated the germline spectrum of LLS patients through whole-exome sequencing (WES). A total of 20 unrelated patients with MMR deficiency who met the clinical criteria for LS and had no germline variant were subjected to germline WES. Variant classification was performed according to the American College of Medical Genetics and Genomics (ACMG) criteria. Pathogenic/likely pathogenic variants were identified in 35% of patients in known cancer genes such as MUTYH and ATM. Besides this, rare and potentially pathogenic variants were identified in the DNA repair gene POLN and other cancer-related genes such as PPARG, CTC1, DCC and ALPK1. Our study demonstrates the germline mutational status of LLS patients, a population at high risk of colorectal cancer.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article